Skip to content

Scribe Therapeutics, Inc.

SCTX Nasdaq SEC CIK 1853921

Follow Scribe Therapeutics Weekly email: filings, results, news

News

3 stories filed under Scribe Therapeutics

Markets

Thread · 2 stories

Guggenheim initiates Scribe Therapeutics stock with buy rating

Markets 37 d ago 2 sources

Scribe Therapeutics stock coverage initiated at Goldman Sachs

Markets 37 d ago also on GS

More coverage

Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics

Tech 20 h ago 2 sources also on TEM

Profile

Headquarters: ALAMEDA, CA, United States
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Peers

Where this page comes from

Profile · SEC EDGAR

News · 3 stories clustered from the RSS aggregator